Reboxetine: tolerability and safety profile in patients with major depression

Since reboxetine acts selectively on the reuptake of noradrenaline, it has a different side‐effects profile than drugs acting predominantly on the serotonin reuptake mechanism. Data from patients treated with reboxetine (n=1503) or placebo/comparator drugs (n=1027) show that reboxetine has no signif...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Acta Psychiatrica Scandinavica 2000-06, Vol.101 (s402), p.37-40
1. Verfasser:	Tanum, Lars
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic Uptake Inhibitors - adverse effects Adrenergic Uptake Inhibitors - therapeutic use Age Factors Antidepressive Agents - adverse effects Antidepressive Agents - therapeutic use Cytochrome P-450 Enzyme System - metabolism Depressive Disorder, Major - drug therapy desipramine Drug Interactions elderly fluoxetine Fluoxetine - therapeutic use Humans imipramine Imipramine - therapeutic use Morpholines - adverse effects Morpholines - therapeutic use Multicenter Studies as Topic Randomized Controlled Trials as Topic reboxetine Therapeutic Equivalency tolerability
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!